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ABSTRACT 
Background & Aims: Dyspepsia and gastro-esophageal reflux are highly prevalent in the 
general population, but they are believed to be separate entities. We conducted a systematic 
review and meta-analysis to estimate the prevalence of dyspepsia in individuals with gastro-
esophageal reflux symptoms (GERS), and to quantify overlap between the disorders.  
Methods: We searched MEDLINE, EMBASE, and EMBASE Classic databases to identify 
population-based studies reporting the prevalence of dyspepsia and GERS in adults, defined 
using specific symptom-based criteria or based on answers to questionnaires. We calculated 
pooled prevalence values, according to study location and criteria used to define weekly 
GERS or dyspepsia, as well as odds ratios (ORs) with 95% CIs. The degree of overlap 
between dyspepsia and GERS was examined.  
Results: Of 14,132 papers evaluated, 79 reported prevalence of weekly GERS. Nineteen of 
these study populations, comprising 111,459 participants, also reported the proportion of 
individuals with dyspepsia. The prevalence of dyspepsia in individuals with weekly GERS 
was 43.9% (95% CI, 35.1–52.9%). The pooled OR for dyspepsia in individuals with weekly 
GERS, compared with those without, was 6.94 (95% CI, 4.33 to 11.1). The OR for dyspepsia 
in individuals with weekly GERS was significantly higher in all geographical regions studied 
and for all diagnostic criteria. The pooled degree of overlap between dyspepsia and GERS 
was 25.9% (95% CI, 19.9%–32.4%). 
Conclusion: The odds of dyspepsia in individuals with weekly GERS is almost 7-fold that of 
individuals without GERS; dyspepsia and GERS overlap in more than 25% of individuals. 
Reasons for this remain speculative, but might include shared pathophysiological 
mechanisms or residual confounding factors. However, patients with GERS should be 
questioned about co-existent dyspepsia, to optimize treatment approaches. 
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INTRODUCTION 
Gastro-esophageal reflux and dyspepsia are both common conditions in the general 
population, with an overall pooled prevalence of approximately 15% and 21% respectively.1, 
2
 Gastro-esophageal reflux is characterized by reflux of stomach contents into the esophagus, 
causing troublesome symptoms. Typical symptoms include heartburn, regurgitation, and 
chest pain 3. The proposed pathogenesis of GERS is multifactorial, including lower 
esophageal pressure abnormalities, lower esophageal sphincter relaxation, hiatus hernia, 
delayed gastric emptying, and visceral hypersensitivity.4-7  
Dyspepsia refers to any symptom felt to originate from the gastroduodenal region, 
according to the Rome Criteria.8-11 The presence of peptic ulcer disease, or rarely gastro-
esophageal malignancy, may cause symptoms of dyspepsia. However, most individuals will 
have no structural explanation for their symptoms and will be labelled as having functional 
dyspepsia.12 There are numerous mechanisms implicated in the pathogenesis of functional 
dyspepsia,13 some of which are common to GERS, including visceral hypersensitivity and 
delayed gastric emptying.14-16 Other proposed mechanisms for functional dyspepsia include 
impaired fundal accommodation, abnormal central pain processing, acute gastroenteritis, and 
chronic infection with Helicobacter pylori (H. pylori).17-20  
Some studies have demonstrated an overlap between GERS and dyspepsia.21, 22 
However, it is not known whether this overlap occurs by chance because they are both 
common disorders, or whether they share common pathophysiology or potential confounding 
factors, such as psychological factors or high levels of somatization. To date, there has been 
no study that synthesizes all available data in order to estimate the prevalence of dyspepsia in 
individuals with GERS. To inform future research on potential shared pathophysiological 
mechanisms, it is important to estimate the strength of association between the two 
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conditions, and whether this association remains stable depending on the criteria used to 
define these conditions, as well as geographic location. Therefore, we have conducted a 
systematic review and meta-analysis of all available population-based cross-sectional 
surveys, to estimate the prevalence of dyspepsia in individuals with GERS compared with 
those without, and to determine the degree of overlap between the two conditions. 
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METHODS 
Search Strategy and Study Selection 
A literature search was performed using EMBASE CLASSIC and EMBASE (1947 to 
September 2016), and MEDLINE (1948 to September 2016) in order to identify only cross-
sectional surveys published in full. The studies had to report the prevalence of GERS and 
dyspepsia in adults (aged ≥15 years). Studies were required to recruit participants from the 
general population or community. Studies reporting data from convenience samples, such as 
those attending screening clinic health check-ups, university students, or employees at an 
institution were ineligible. To be eligible, studies had to recruit ≥50 participants and report 
prevalence of both weekly GERS and dyspepsia within the same study population. These 
eligibility criteria, which were defined prospectively, are provided in Box 1.  
The medical literature was searched using the following terms: heartburn, GERD, 
gastro-esophageal reflux disease, gastro-esophageal reflux, esophageal reflux (both as a 
medical subject heading (MeSH) and free text term), acid regurgitation, GORD, or upper 
gastrointestinal symptoms (as free text terms). These were combined using the set operator 
AND with studies identified with the terms: prevalence, incidence, or frequency (both as 
MeSH and free text terms), or proportion (as a free text term). The resulting abstracts were 
screened for potential suitability by two investigators, and those that appeared relevant were 
retrieved and examined in detail. There were no language restrictions. Foreign language 
articles were translated, where required. A recursive search of the bibliographies of all 
articles was performed. Where there appeared to be multiple study reports from the same 
group of subjects, we contacted the authors to clarify this issue. Eligibility assessment was 
performed independently by two investigators, using pre-designed eligibility forms, with 
disagreements resolved via a third investigator. 
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Data Extraction 
Data were extracted independently by two investigators on to a Microsoft Excel 
spreadsheet (XP professional edition; Microsoft, Redmond, WA, USA), again with any 
discrepancies resolved via a third investigator. The following data were collected for each 
study: year(s) conducted, country and geographical region, method of symptom data 
collection, criteria used to define GERS, criteria used to define dyspepsia, number of subjects 
providing complete data, number of subjects with weekly GERS, number of subjects with 
dyspepsia, and number of subjects meeting the criteria for dyspepsia among those with or 
without weekly GERS. We assessed quality of the identified and included studies using an 
adapted version of published, non-validated, criteria for prevalence studies such as these.23 
Studies are graded according to eight methodological criteria, with a total possible score from 
0 to 8. No threshold was recommended by the authors to define a high-quality study, but we 
used a score of ≥5. 
The degree of overlap between the two conditions was examined by extracting the 
total number of individuals who met the criteria for both GERS and dyspepsia 
simultaneously, for each study, and expressing this as a proportion of the total number of 
subjects who reported symptoms compatible with either condition. We studied the effect of 
varying the definitions of GERS or dyspepsia on the degree of overlap observed. 
 
Data Synthesis and Statistical Analysis 
The proportion of individuals with dyspepsia was combined for all studies according 
to presence or absence of weekly GERS. The prevalence of dyspepsia in those with and 
without weekly GERS was then compared using an odds ratio (OR) with a 95% confidence 
interval (CI). Heterogeneity between studies was assessed using the I2 statistic, with a cut off 
of 50%, and the χ2 test with a P value <0.10, used as the threshold for statistically significant 
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heterogeneity.24 We planned to conduct subgroup analyses according to geographical region, 
diagnostic criteria used to define weekly GERS, and diagnostic criteria used to define 
dyspepsia, to examine whether this had any effect on the ORs for dyspepsia in individuals 
with weekly GERS compared with those without.  
Data were pooled using a random effects model to give a more conservative estimate 
of the prevalence of, and the odds of, dyspepsia in individuals with weekly GERS.25 
StatsDirect version 2.7.2 (StatsDirect, Sale, Cheshire, England) was used to generate Forest 
plots of pooled prevalences and pooled ORs with 95% CIs. Evidence of publication bias was 
assessed for by applying Egger’s test to funnel plots of ORs,26 where a sufficient number of 
studies (≥10) were available.27 The degree of overlap between the two conditions was 
examined, whilst varying the specific diagnostic criteria used for weekly GERS or dyspepsia, 
where more than one study existed for each definition, by comparing the number of 
individuals meeting criteria for both conditions as a proportion of all individuals meeting 
criteria for either condition using a χ2-test. 
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RESULTS 
The search strategy identified 14,132 citations. From these we identified 365 that 
appeared to be relevant to the study question. Of these, there were 79 separate adult study 
populations reporting the prevalence of weekly GERS, of which 19 also reported the 
proportion of individuals with dyspepsia (Figure 1).21, 28-45 Agreement between investigators 
for assessment of study eligibility was perfect (κ-statistic = 1.0). Detailed characteristics of 
all included studies are provided in Table 1. Except for the article by Reshetnikov et al.37 that 
was written in Russian, all other included studies were published in English language. 
Individual quality items for each of the included studies are provided in Supplementary Table 
1. Ten studies achieved a score of ≥5 using these quality criteria.21, 33-38, 42-44 
The 19 included studies contained 111,459 subjects and were geographically diverse, 
with 8 studies from Europe,31, 34, 36, 37, 39, 43-45 four from Asia,32, 38, 40, 42 four from North 
America,21, 28, 30, 35 and one each from the Middle East,41 Australasia,29 and South America.33 
Six studies defined weekly GERS using the Montreal criteria,37, 39, 40, 42, 43, 45 six the bowel 
disease questionnaire 21, 28-30, 32, 35, four the Mayo reflux questionnaire 33, 36, 41, 44, and three 
another validated questionnaire.31, 34, 38 There was a wide variation in the prevalence of 
weekly GERS, which ranged from 3.1% 40 to 34.4%,34 within the 19 included study 
populations. The pooled prevalence of weekly GERS was 15.4% (95% CI 12.5% to 18.6%), 
with statistically significant heterogeneity between studies (I2 = 99.4%, P < 0.001). 
In terms of the definition of dyspepsia used, there were four studies that used the 
Rome I criteria,29, 30, 32, 37 four the Rome II criteria,35, 38-40 five the Rome III criteria,21, 31, 42, 43, 
45
 three defined presence of dyspepsia according to the Mayo reflux questionnaire (which 
defines dyspepsia using questions extracted directly from the previously validated bowel 
disease questionnaire),33, 36, 44 and three used another validated questionnaire.28, 31, 34  The 
prevalence of dyspepsia reported by included studies ranged from 2.4% 40 to 48.4%,34 with a 
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pooled prevalence of 17% (95% CI 13.4% to 20.9%), again with statistically significant 
heterogeneity between studies (I2 = 99.6%, P < 0.001). 
 
Prevalence of Dyspepsia in Individuals with Weekly GERS Compared with Individuals 
without Weekly GERS, Regardless of Diagnostic Criteria Used  
The prevalence of dyspepsia in subjects with weekly GERS varied from 6.5% 40 to 
86.3%,34 with a pooled prevalence of 43.9% (95% CI 35.1% to 52.9%). There was significant 
heterogeneity between studies (I2 = 98.7%, P < 0.001). The prevalence of dyspepsia in 
individuals without weekly GERS varied from 0.8% 45 to 33.1%,37 with a pooled prevalence 
of 11.7% (95% CI 9.0% to 14.6%), again with significant heterogeneity between studies (I2 = 
99.4%, P < 0.001). The pooled OR for dyspepsia in individuals with weekly GERS, 
compared with those without, was 6.94 (95% CI 4.33 to 11.1, I2 = 98.6%, P < 0.001, Figure 
2), with no evidence of funnel plot asymmetry (Egger test, P = 0.17).  
A subgroup analysis was performed according to geographical location of the studies 
(Table 2), without revealing any obvious explanation for the heterogeneity observed between 
studies. The odds of dyspepsia in those with weekly GERS, compared with those without, 
remained significantly higher in all these analyses. The OR was highest in the study 
conducted in Middle East and lowest in the South American study.  
 
Prevalence of Dyspepsia in Individuals with Weekly GERS Compared with Individuals 
without GERS, According to Diagnostic Criteria Used  
A further subgroup analyses was conducted according to the diagnostic criteria used 
to define weekly GERS or dyspepsia (Table 2). When criteria for weekly GERS were 
examined individually, there were no obvious causes for the heterogeneity observed between 
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studies, although heterogeneity was somewhat lower when the bowel disease questionnaire 
was used. The OR was higher when the Montreal criteria were used (OR = 7.20; 95% CI 4.02 
to 12.9, I2 = 96.3%, P < 0.001), but were highest in studies that used another validated 
questionnaire to define the presence of weekly GERS (OR = 10.4; 95% CI 4.97 to 21.6, I2 = 
93.1%, P < 0.001). 
When criteria used to define dyspepsia were examined, there was still significant 
heterogeneity detected between studies regardless of which criteria were used. The OR was 
highest when the Rome III criteria were used to define the presence of dyspepsia (20.6; 95% 
CI 6.86 to 61.6, I2 = 99.4%, P < 0.001), and lowest when the Mayo reflux questionnaire was 
used to define dyspepsia (2.48; 95% CI 1.31 to 4.69, I2 = 90.3%, P < 0.001).  
 
Degree of Overlap Between Dyspepsia and Weekly GERS 
The degree of overlap between weekly GERS and dyspepsia varied from 3.8% 40 to 
55.9%,34 with a pooled value of 25.9% (95% CI 19.9% to 32.4%, I2 = 98.6%, P < 0.001). 
When specific diagnostic criteria for weekly GERS were applied, using any definition of 
dyspepsia, the degree of overlap was lowest when the bowel disease questionnaire was used 
(22.0%), and highest when the Mayo reflux questionnaire was used (42.6%). This difference 
was statistically significant (χ2 = 240.1, P < 0.001). When specific diagnostic criteria were 
used for dyspepsia, applying any definition of weekly GERS, overlap was lowest when the 
Rome II criteria were used to define presence of dyspepsia (17.0%), and highest when the 
Rome III criteria were used (28.9%).  This difference was also statistically significant (χ2 = 
125.2, P < 0.001). 
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DISCUSSION 
This systematic review and meta-analysis has collected data from all available and 
identified population-based cross-sectional surveys reporting the prevalence of dyspepsia 
according to the presence of GERS. We have demonstrated a prevalence of dyspepsia in 
individuals with weekly GERS almost seven-fold that of individuals without GERS. The 
positive association between dyspepsia and weekly GERS remained according to all 
geographical locations examined. The positive association between the two persisted for 
almost all definitions of GERS and each definition of dyspepsia used, although the degree of 
association varied considerably in these analyses. The pooled OR for dyspepsia in individuals 
with weekly GERS was highest when the Gastrointestinal Symptom Rating Scale 34 or the 
Leeds Dyspepsia Questionnaire 31 were used to define GERS, and when the Rome III criteria 
were used to define dyspepsia. The degree of overlap between GERS and dyspepsia varied 
between 3.8% and 55.9%, depending on the diagnostic criteria used to define each condition. 
Higher amounts of overlap were found when GERS was defined according to the Mayo 
reflux questionnaire, and when presence of dyspepsia was defined according to Rome III 
criteria. 
We used rigorous methodology and a contemporaneous literature search, which 
allowed the pooling of data from more than 100,000 individuals. Judging of study eligibility 
and data extraction were carried out by two investigators independently, with discrepancies 
resolved by consensus. Foreign language articles were also included, after translation. A 
random effects model was used to pool data, in order to provide a more conservative estimate 
of the pooled OR for dyspepsia in GERS. We also assessed for evidence of publication bias, 
or other small study effects, by testing funnel plots for obvious asymmetry. Finally, we 
limited studies to those based in the general population, and excluded those conducted among 
convenience samples, which should reduce the likelihood that the reported prevalence of 
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either GERS or dyspepsia were inflated, and the data reported should therefore be 
generalisable to individuals in the community.  
Limitations of this study include the fact that half (10 out of 19) of the studies we 
identified scored 3 or less (of a possible total score of 6) on the quality scale we used,23 
although this has not been validated, and there is no recommendation as to what threshold 
should be used to define higher-quality studies. Since the included studies were mainly 
observational, the majority of the subjects were not required to undergo upper endoscopy as 
part of the studies, thus dyspepsia in these studies was mostly uninvestigated, rather than 
truly functional, despite the use of various iterations of the Rome criteria in many studies. 
Moreover, the methods and criteria used to define presence of GERS and dyspepsia varied 
between individual studies, according to both frequency and duration of symptoms in some 
instances. In order to minimize this variation, we included only studies that reported a weekly 
prevalence of GERS and, in addition, we performed subgroup analyses according to criteria 
used to define dyspepsia and GERS, as well as geographical location. However, significant 
heterogeneity between studies persisted in most of these analyses. The reasons for the 
heterogeneity are therefore speculative and, other than subtle differences in the diagnostic 
criteria used, may include other demographic or cultural differences between study 
populations, including ethnicity, which it was not possible to examine using the data 
available for extraction. Another limitation is the paucity or absence of studies reporting the 
prevalence of GERS and dyspepsia for some geographical regions, such as the Middle East, 
Central and South America, and Africa. 
Although most subjects in the studies identified in this systematic review and meta-
analysis had symptoms that could be classified as either GERS alone or dyspepsia alone, our 
results still demonstrate that, in almost half of these individuals, there was overlap between 
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the two conditions, and that individuals with GERS were at significantly increased risk of co-
existent dyspepsia. These data suggest that the overlap of dyspepsia and GERS is not 
explained by chance alone, although the reasons for this overlap cannot be elucidated by a 
study such as ours. Although the pathophysiology of both GERS and dyspepsia has been 
studied extensively, there has been little research that has focused specifically on patients 
with both of these disorders. The two diseases are frequently chronic, and may share 
pathophysiological mechanisms, including visceral hypersensitivity and altered 
gastrointestinal (GI) motility.14, 46, 47 In particular, impaired gastric accommodation is 
considered to play important role in the pathogenesis of functional dyspepsia, and has been 
found in approximately 40% of cases.48 Gastric wall tension and antral over-distension are 
among the main mechanisms involved in generating dyspeptic symptoms. Moreover, 
prolonged postprandial gastric distention and increased basal intragastric pressure lead to an 
increased gastro-esophageal pressure gradient, favoring spontaneous reflux. Therefore, since 
impaired gastric accommodation has also been reported in 25-40% of patients with GERD, 
gastric motility issues could explain some of the overlap of GERS and dyspepsia that we 
observed.49 
In addition, acid-related mechanisms have been considered to play an important role 
in patients with overlapping functional dyspepsia and heartburn. Several studies have 
reported that a subgroup of patients with functional dyspepsia have pathological acid reflux, 
based on abnormal 24-hour esophageal pH monitoring.46, 50 An important role has also been 
attributed to psychological factors, and high levels of somatization, in particular depression, 
anxiety, and insomnia appear to predict symptom overlap between dyspepsia and GERS.22 
This has led some authors to suggest that the overlap group may represent a distinct 
syndrome.21, 51 Moreover, not all patients reporting presence of heartburn suffer from gastro-
esophageal reflux disease (GERD). Savarino et al. studied a cohort of patients with GERS, 
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but normal upper GI endoscopy. All patients underwent 24-hour pH-impedance monitoring 
and the symptom association probability (SAP) for typical esophageal symptoms was 
calculated for each subject. One-quarter of the patients were classified as having functional 
heartburn (negative pH-impedance study and SAP), and these patients showed significantly 
higher rates of dyspeptic symptoms compared with patients with a positive pH-impedance 
study and/or positive SAP. This led the authors to conclude that functional heartburn seemed 
to have more in common with functional dyspepsia than with non-erosive GERD.52 
The role of H. pylori has been widely investigated in the pathogenesis of both 
dyspepsia and reflux disease. The infection seems to cause dyspeptic symptoms in some 
individuals, as confirmed by epidemiological studies 31, 53 and most of all by H. pylori 
eradication studies. Indeed, in infected patients with uninvestigated or functional dyspepsia, 
H. pylori eradication produces long-term relief of dyspepsia in about 10% of patients 
compared with placebo.54 On the contrary, at a population level, H. pylori infection is 
negatively associated with GERS, and also with their sequelae, such as Barrett’s esophagus 
and esophageal adenocarcinoma;55-57 nevertheless, its eradication seems neither to cause nor 
exacerbate reflux disease. Among the studies included in our meta-analysis, only two 
reported the overall prevalence of H. pylori infection in their study population, with rates 
ranging from 27.7% in the UK 31 to 57.7% in Italy.39 Two other studies reported partial data 
on H. pylori infection,37, 40 but the majority of studies analyzed symptom questionnaires 
without evaluating the infection status of included individuals. 
Other genetic and pathophysiological risk factors may differ according to ethnicity, 
and this could lead to differences in the co-existence of GERS and dyspepsia according to 
geographical region. Nevertheless, with the exception of the single study performed in 
Middle East reporting an OR of 78.2, the subgroup analyses examining this issue did not 
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reveal any obvious underlying differences in the degree of overlap between the two 
conditions, with ORs ranging from 6.23 in Asia to 6.79 in Europe, whereas ORs for 
dyspepsia in subjects with GERS of lesser magnitude were found in South America and 
Australasia, although only two studies reported data from these regions.  
We also conducted subgroup analyses according to the criteria used to define each 
condition. We expected these to lead to a reduction in heterogeneity between studies, due to a 
more uniform definition of each of the two disorders. However, this was not the case, 
although a lower amount of heterogeneity was seen when studies that used the Rome I and II 
criteria to define the presence of dyspepsia were pooled. We also found a lower OR for 
dyspepsia in GERS when the Mayo reflux questionnaire was used to define dyspepsia. 
However, this questionnaire was primarily designed to identify individuals with GERS, and 
considers only a limited range of symptoms for the diagnosis of dyspepsia (pain or aching in 
the upper abdominal area only) compared with the more widely accepted Rome criteria. 
Therefore, using this questionnaire in the community may have underestimated the true 
prevalence of dyspepsia.  
These methodological differences reflect the complexity of defining dyspepsia in the 
community, which is echoed by an evolution of the Rome criteria over the years. Within the 
Rome II criteria functional dyspepsia was defined as pain or discomfort centered in the upper 
abdomen, with no emphasis given to meal-related symptoms.11 From Rome III onwards, 
different symptom clusters based on meal-induced and meal-unrelated symptoms have been 
introduced, distinguishing between postprandial distress syndrome and epigastric pain 
syndrome, with the aim being to create more homogenous patient groups.10 The Rome III 
criteria also highlighted the issue that any overlap of GERD with dyspepsia needs to be 
carefully evaluated, in order to exclude from the diagnosis of functional dyspepsia subjects 
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with isolated/predominant GERS from the diagnosis of functional dyspepsia. However, in a 
study conducted in a primary care setting in Europe and Canada, which assessed the validity 
of the Rome III criteria to both distinguish between and subgroup patients with upper GI 
symptoms undergoing upper GI endoscopy and 48-hour pH monitoring,58 75% of patients 
with confirmed GERD met criteria for functional dyspepsia, and >50% with confirmed 
functional dyspepsia reported GERS. The authors concluded that, even after exhaustive 
investigation, discriminating between these two conditions accurately was difficult. 
Our meta-analysis only included studies that reported the overlap of GERS and 
dyspepsia in the community, but studies from convenience samples also support our findings. 
In a cross-sectional survey of Japanese patients attending for upper GI endoscopy, the overlap 
between GERS and dyspepsia according to the Montreal definition and the Rome III criteria 
was 30%.59 Similarly, Xiao et al. evaluated consecutive dyspeptic patients who fulfilled the 
Rome III criteria and who underwent upper GI endoscopy and had ambulatory 24-hour pH 
monitoring, confirming that evidence of pathological acid reflux was present in almost one-
third of patients with dyspepsia and, in particular, the prevalence was about 50% in those 
with epigastric burning.60 Moreover, the PPI test had a limited ability to distinguish those 
with dyspeptic symptoms from those with GERD. 
In conclusion, this systematic review and meta-analysis has demonstrated that the 
prevalence of dyspepsia in individuals with GERS is almost seven-fold that of subjects 
without GERS, and that there is overlap between the two conditions in up to one-quarter of 
individuals. Making a diagnosis of GERD versus dyspepsia based on upper GI symptoms 
alone is difficult, and even when investigations are requested in an attempt to further 
delineate these two patient groups, overlap persists. The reasons for this remain speculative, 
but may include shared pathophysiological mechanisms or other demographic features that 
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are associated with both conditions.  
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Box 1: Eligibility Criteria 
Cross-sectional surveys 
Recruited adults (>90% of participants aged ≥15 years) 
Participants recruited from the general population / community* 
Reported prevalence of both dyspepsia and gastro-esophageal reflux-type symptoms within 
the same study population (according to a questionnaire, or specific diagnostic criteria†) 
Sample size of ≥50 participants      
 
*Convenience samples excluded 
† For dyspepsia, these included the Rome I, II, or III criteria. For gastroesophageal reflux 
symptoms (GERS), these included the Montreal criteria. 
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FIGURES 
Figure 1. Flow Diagram of Assessment of Studies Identified in the Systematic Review and 
Meta-analysis.  
Figure 2. Pooled Odds Ratio for Dyspepsia in Those with Weekly GERS Compared with 
Those without GERS.  
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Table 1. Characteristics of Included Studies. 
Author and 
publication year 
(ref) 
Country Method of data 
collection 
Criteria used to define 
weekly GERS 
Criteria used to 
define dyspepsia 
Total no. 
of patients 
No. with 
weekly 
GERS (%) 
No. with 
dyspepsia (%) 
Total quality 
score 
(maximum of 6) 
Talley 1994 28 USA Postal 
questionnaire 
Bowel Disease 
Questionnaire 
Bowel Disease 
Questionnaire 
919 100 (10.9) 200 (21.8) 2 
Talley 1998 29 Australia Postal 
questionnaire 
Bowel Disease 
Questionnaire / Bowel 
Symptom Questionnaire 
Rome I 774 168 (21.7) 92 (11.9) 2 
Locke 2000 30 USA Postal 
questionnaire 
Bowel Disease 
Questionnaire 
Rome I 643 128 (19.9) 89 (13.8) 3 
Moayyedi 2000 31 UK Interview-
administered 
questionnaire 
Leeds Dyspepsia 
Questionnaire 
Leeds Dyspepsia 
Questionnaire 
8404 1289 (15.3) 954 (11.4) 1 
Hu 2002 32 China Telephone 
interview 
Bowel Disease 
Questionnaire 
Rome I 1649 79 (4.8) 304 (18.4) 3 
Chiocca 2005 33 Argentina Postal 
questionnaire 
Mayo Reflux 
questionnaire 
Mayo Reflux 
Questionnaire 
837 194 (23.2) 257 (30.7) 3 
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Papatheodoridis 
2005 34 
Greece Face-to-face 
interview 
Gastrointestinal Symptom 
Rating Scale 
Gastrointestinal 
Symptom Rating 
Scale 
700 241 (34.4) 339 (48.4) 4 
Choung 2007 35 * USA Postal 
questionnaire 
Bowel Disease 
Questionnaire 
Rome II 2273 411 (18.1) 351 (15.4) 4 
Kitapcioglu 2007 
36
 
Turkey Face-to-face 
interview 
Mayo Reflux 
questionnaire 
Mayo Reflux 
Questionnaire 
630 126 (20) 180 (28.6) 4 
Reshetnikov 2009 
37
 
Russia Self-completed 
questionnaire 
Montreal criteria Rome I 1040 177 (17) 390 (37.5) 4 
Lee 2009 38 South Korea Interview-
administered 
questionnaire 
Questionnaire (weekly 
heartburn and/or 
regurgitation) 
Rome II 1443 123 (8.5) 137 (9.5) 4 
Zagari 2010 39 Italy Interview-
administered 
questionnaire 
Montreal criteria Rome II 1033 258 (25) 285 (27.6) 3 
Zhao 2010 40 China Self-completed 
questionnaire 
Montreal criteria Rome II 16078 496 (3.1) 387 (2.4) 3 
Moghimi-
Dehkordi 2011 41 
Iran Face-to-face 
interview 
Mayo Reflux 
questionnaire 
Rome III 18180 1525 (8.4) 1411 (7.8) 3 
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Choung 2012 21 USA Postal 
questionnaire 
Bowel Disease 
Questionnaire 
Rome III 3517 404 (11.5) 344 (9.8) 3 
Min 2014 42 South Korea Telephone 
interview 
Montreal criteria Rome III 5000 356 (7.1) 384 (7.7) 4 
Rasmussen 2015 43 Denmark Self-completed / 
Telephone 
questionnaire 
Montreal criteria Rome III 47090 5264 (11.2) 3599 (7.6) 4 
Bor 2016 44 Russia Face-to-face 
interview 
Mayo Reflux 
questionnaire 
Mayo Reflux 
Questionnaire 
1065 251 (23.6) 360 (33.8) 4 
Chirila 2016 45 Romania Interview-
administered 
questionnaire 
Montreal criteria Rome III 184 57 (31) 14 (7.6) 4 
* data also extracted from Jung et al. 2007 56 
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Table 2. Pooled Odds Ratios for Dyspepsia in Those with Weekly GERS Compared with Those without Weekly GERS According to 
Geographical Location and Criteria Used to Define Dyspepsia or Weekly GERS. 
 
 
Number of 
studies 
Number of 
subjects 
Odds ratio 
95% confidence 
interval 
I2 
P value for 
X2 
All studies 19 111,459 6.94 4.33 – 11.1 98.6% < 0.001 
Geographical region       
North American studies 4 7,352 6.41 4.37 – 9.39 81.1% < 0.001 
South American studies 1 837 1.60 1.12 – 2.26 N/A N/A 
European studies 8 60,146 6.79 4.39 – 10.5 96.1% < 0.001 
Northern European studies 4 57,599 6.68 3.89 – 11.5 97.5% < 0.001 
Southern European studies 4 2,547 7.61 2.87 – 20.2 93.8% < 0.001 
Middle Eastern studies 1 18,180 78.2 67.47 – 90.6 N/A N/A 
Asian studies 4 24,170 6.23 2.18 – 17.8 96.9% < 0.001 
Australasian studies 1 774 4.13 2.55 – 6.64 N/A N/A 
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Criteria used to define GERS       
Bowel Disease Questionnaire 6 9,775 5.83 4.37 – 7.76 73.0% < 0.001 
Mayo Reflux questionnaire 4 20,712 5.88 0.60 – 57.5 99.6% < 0.001 
Montreal criteria 6 70,425 7.20 4.02 – 12.9 96.3% < 0.001 
Other questionnaires 3 10,547 10.4 4.97 – 21.6 93.1% < 0.001 
Criteria used to define Dyspepsia       
Mayo Reflux questionnaire 3 2,532 2.48 1.31 – 4.69 90.3% < 0.001 
Rome I 4 4,106 4.55 2.30 – 6.90 73.8% < 0.001 
Rome II 4 20,827 4.32 3.15 – 5.91 71.5% < 0.001 
Rome III 5 73,971 20.6 6.86 – 61.6 99.4% < 0.001 
Other questionnaires 3 10,023 12.5 8.14 – 19.3 80% < 0.001 
* N/A; not applicable, too few studies to assess heterogeneity 
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Supplementary Table 1. Quality Rating of Included Studies 
Study Random 
sample or 
whole 
population 
Unbiased 
sampling 
frame (e.g. 
census data) 
Appropriate measure 
used (e.g. validated 
questionnaire or 
criteria) 
Outcomes 
measured by 
unbiased 
assessors 
Adequate response 
rate (70%), non-
responders 
described 
Study 
subjects 
described 
Total score 
(maximum 
of 6) 
Talley 1994 28 1 0 0 0 1 0 2 
Talley 1998 29 1 0 1 0 0 0 2 
Locke 2000 30 1 0 1 0 1 0 3 
Moayyedi 2000 31 1 0 0 0 0 0 1 
Hu 2002 32 1 0 1 0 0 1 3 
Chiocca 2005 33 1 0 1 0 1 0 3 
Papatheodoridis 2005 34 1 0 1 0 1 1 4 
Choung 2007 35  1 0 1 0 1 1 4 
Kitapcioglu 2007 36 1 1 1 0 1 0 4 
Reshetnikov 2009 37 1 1 1 0 0 1 4 
Lee 2009 38 1 1 1 0 0 1 4 
Zagari 2010 39 1 0 1 0 1 0 3 
Zhao 2010 40 1 0 1 0 0 1 3 
Moghimi-Dehkordi 2011 41 1 0 1 0 1 0 3 
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Choung 2012 21 1 0 1 0 0 1 3 
Min 2014 42 1 0 1 0 1 1 4 
Rasmussen 2015 43 1 1 1 0 0 1 4 
Bor 2016 44 1 0 1 0 1 1 4 
Chirila 2016 45 1 0 1 0 1 1 4 
 
